Skip to main content

Amgen news and events in 2026

Amgen is a biopharmaceutical organization that discovers, develops, and manufactures medicines. The organization focuses on creating therapeutic treatments for cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.

Public (AMGN)Biotechnology Research10,000+ employeesamgen.comLinkedIn

Get Amgen's live signals in Claude or ChatGPT, or by API

AskWhat changed at Amgen this week? Use Autobound signals for amgen.com.
Dated updates
83
Last event
Nov 17, 2026
Open rolesSnapshot Nov 17, 2026
260
Latest SEC filing
Nov 3, 2026

Source: Autobound Signal API · 83 signals tracked for Amgen · updated

Overview

Amgen by topic

Latest events

Latest Amgen events

  1. Revenue
    AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTSAmgen reported total product sales of $9,883 million for the third quarter of 2026.
  2. Executive hire
    AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORSDavid W. Gibbs, Member of the Board of Directors
  3. Earnings
    Amgen reports Phase 3 results and Amgen stock trades at EUR 371.13Amgen reported adjusted earnings per share of USD 6.29 for the second quarter of 2026, surpassing the consensus estimate of USD 5.62.
  4. In development
  5. Integration
  6. In development
    Cholesterol drug setback casts doubt over multibillion-dollar raceAmgen is developing a drug, olpasiran, to lower Lp(a) cholesterol as a rival treatment to Novartis's pelacarsen.
  7. Partnership
  8. In development
  9. Revenue
    Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes TherapeuticsAmgen's product Imdelltra reported revenue of more than USD 600 million in 2025.
  10. New location
    Amgen (AMGN) Opens New Science And Innovation Center In HyderabadAmgen has opened a new Science and Innovation Center in Genome Valley, Hyderabad, to expand its global research and development presence.

Showing 10 of 24 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Amgen with the Signal API

One POST /v1/companies/enrich call with amgen.com returns every signal type for Amgen, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"amgen.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Amgen questions

What is the latest news on Amgen?
On Nov 3, 2026, prnewswire.com reported: AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS. This page tracks 24 news events for Amgen since Dec 9, 2025, each with a date and a source link.
What is going on with Amgen?
In the 90 days to Nov 19, 2026, Autobound tracked 8 news events, 1 10-Q filing, 1 8-K filing, 4 hiring snapshots, 1 executive move, 31 signals for Amgen. The newest story is from Nov 3, 2026 (Revenue), reported by prnewswire.com.
What else does Autobound track for Amgen?
Beyond news and filings, Autobound lists 46+ signals for Amgen from 4 sources: Glassdoor (15+), LinkedIn (15+), Patents (11), Reddit (5). See the Amgen signals page for the dated list.
Is Amgen hiring right now?
Yes. As of Nov 17, 2026, Amgen had 260 open roles, and Engineering had the most with 24.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →